Anti-KCTD8 monoclonal antibody

Pre-made anti-KCTD8 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KCTD8/KCTD8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1040-Ab-1/ GM-Tg-hg-IP1040-Ab-2Anti-Human KCTD8 monoclonal antibodyHuman
GM-Tg-rg-IP1040-Ab-1/ GM-Tg-rg-IP1040-Ab-2Anti-Rat KCTD8 monoclonal antibodyRat
GM-Tg-mg-IP1040-Ab-1/ GM-Tg-mg-IP1040-Ab-2Anti-Mouse KCTD8 monoclonal antibodyMouse
GM-Tg-cynog-IP1040-Ab-1/ GM-Tg-cynog-IP1040-Ab-2Anti-Cynomolgus/ Rhesus macaque KCTD8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1040-Ab-1/ GM-Tg-felg-IP1040-Ab-2Anti-Feline KCTD8 monoclonal antibodyFeline
GM-Tg-cang-IP1040-Ab-1/ GM-Tg-cang-IP1040-Ab-2Anti-Canine KCTD8 monoclonal antibodyCanine
GM-Tg-bovg-IP1040-Ab-1/ GM-Tg-bovg-IP1040-Ab-2Anti-Bovine KCTD8 monoclonal antibodyBovine
GM-Tg-equg-IP1040-Ab-1/ GM-Tg-equg-IP1040-Ab-2Anti-Equine KCTD8 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1040-Ab-1/ GM-Tg-hg-IP1040-Ab-2; GM-Tg-rg-IP1040-Ab-1/ GM-Tg-rg-IP1040-Ab-2;
GM-Tg-mg-IP1040-Ab-1/ GM-Tg-mg-IP1040-Ab-2; GM-Tg-cynog-IP1040-Ab-1/ GM-Tg-cynog-IP1040-Ab-2;
GM-Tg-felg-IP1040-Ab-1/ GM-Tg-felg-IP1040-Ab-2; GM-Tg-cang-IP1040-Ab-1/ GM-Tg-cang-IP1040-Ab-2;
GM-Tg-bovg-IP1040-Ab-1/ GM-Tg-bovg-IP1040-Ab-2; GM-Tg-equg-IP1040-Ab-1/ GM-Tg-equg-IP1040-Ab-2
Products NameAnti-KCTD8 monoclonal antibody
Formatmab
Target NameKCTD8
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KCTD8 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1040-Ag-1Recombinant multi-species KCTD8 protein


    Target information

    Target IDGM-IP1040
    Target NameKCTD8
    Gene ID386617,243043,364148,703107,610705,101091620,539881,100062435
    Gene Symbol and SynonymsA730087N02Rik,KCTD8
    Uniprot AccessionQ6ZWB6
    Uniprot Entry NameKCTD8_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183783
    Target ClassificationN/A

    The target: KCTD8, gene name: KCTD8, also named as . Predicted to be involved in regulation of G protein-coupled receptor signaling pathway. Predicted to be located in cell projection; postsynaptic membrane; and presynaptic membrane. Predicted to be integral component of membrane. Predicted to be part of receptor complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.